Cervical Cancer Industry Statistics

Cervical cancer remains a significant global health issue, with approximately 570,000 new cases and 310,000 deaths reported each year, disproportionately affecting low- and middle-income countries.

Statistic 1

"Cervical cancer is the fourth most common cancer in women worldwide."

Sources Icon

Statistic 2

"In 2020, an estimated 604,000 women were diagnosed with cervical cancer worldwide."

Sources Icon

Statistic 3

"Cervical cancer caused about 342,000 deaths globally in 2020."

Sources Icon

Statistic 4

"In 2018, nearly 90% of cervical cancer deaths occurred in low- and middle-income countries."

Sources Icon

Statistic 5

"Human papillomavirus (HPV) types 16 and 18 cause around 70% of cervical cancers and pre-cancerous cervical lesions."

Sources Icon

Statistic 6

"Clinical trial spending for cervical cancer treatments exceeded USD 300 million in the United States in 2020."

Sources Icon

Statistic 7

"There were approximately 1,500 clinical trials focusing on cervical cancer worldwide in 2019."

Sources Icon

Statistic 8

"Sales of cervical cancer drugs exceeded USD 1.3 billion in the United States in 2018."

Sources Icon

Statistic 9

"Approximately 84% of cervical cancers are found in the developing world, where there are fewer resources for prevention, screening, and treatment."

Sources Icon

Statistic 10

"The five-year survival rate for cervical cancer when detected at an early stage is approximately 92%."

Sources Icon

Statistic 11

"The global HPV testing & Pap test market generated revenue of approximately USD 3.2 billion in 2015."

Sources Icon

Statistic 12

"Between 2020 and 2030, the market for cervical cancer therapeutics is expected to expand at a CAGR of approximately 6%."

Sources Icon

Statistic 13

"Research and development expenditure of cervical cancer drugs in the U.S alone surpassed USD 100 million in 2020."

Sources Icon

Statistic 14

"In 80% of cases, cervical cancer is found in women over the age of 50."

Sources Icon

Statistic 15

"The cervical cancer treatment market in Europe is anticipated to witness significant growth owing to the presence of a well-established healthcare infrastructure."

Sources Icon

Statistic 16

"The cervical cancer therapeutics market in Latin America is anticipated to expand at a CAGR of 6%, driven by the increasing incidence of the disease."

Sources Icon

Statistic 17

"Cervical cancer is the second most common cancer among women aged 15 to 44 in the Middle East and Africa region."

Sources Icon

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!